http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3267787

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 5801
issn 1557-3265
1078-0432
issueIdentifier 19
pageRange 5789-5801
publicationName Clinical cancer research : an official journal of the American Association for Cancer Research
startingPage 5789
bibliographicCitation Ahern E, Harjunpää H, Barkauskas D, Allen S, Takeda K, Yagita H, Wyld D, Dougall WC, Teng MWL, Smyth MJ. Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice. Clin Cancer Res. 2017 Oct 01;23(19):5789–801. doi: 10.1158/1078-0432.ccr-17-0606. PMID: 28634284.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6be3cce279f6c0e2f8b2590c65205a41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70f2d4f8669fd31349e21704f97e79b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e575d63490a3ddd848cd8700d6bf346
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bc3aec9a79071e2117a6ded5f2cac942
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_48e0731326ffdd9c3c3764e20f165048
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7df3a3b1c0bfed379445a496e61210df
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_14732b3c0d3b7eccf4d26d85f975808c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab1512d86e9c733290b10b4579e6924c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4ef406b471c586e196f35fdfe7ffbbf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaded17cb0d12c8e7783aa13b94afe52
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1380-9939
date 2017-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1158/1078-0432.ccr-17-0606
https://pubmed.ncbi.nlm.nih.gov/28634284
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8794
https://portal.issn.org/resource/ISSN/1078-0432
https://portal.issn.org/resource/ISSN/1557-3265
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice
discusses http://id.nlm.nih.gov/mesh/M0024747
http://id.nlm.nih.gov/mesh/M0281672
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0281676
http://id.nlm.nih.gov/mesh/M0522233
http://id.nlm.nih.gov/mesh/M0024087
http://id.nlm.nih.gov/mesh/M0282800
http://id.nlm.nih.gov/mesh/M0371270
http://id.nlm.nih.gov/mesh/M0555800
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D053246Q000235
http://id.nlm.nih.gov/mesh/D053245Q000276
http://id.nlm.nih.gov/mesh/D008546Q000628
http://id.nlm.nih.gov/mesh/D007167
http://id.nlm.nih.gov/mesh/D060908Q000276
hasSubjectTerm http://id.nlm.nih.gov/mesh/D050378Q000276
http://id.nlm.nih.gov/mesh/D008214Q000276
http://id.nlm.nih.gov/mesh/D016207Q000235
http://id.nlm.nih.gov/mesh/D008546Q000276
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D008546Q000235
http://id.nlm.nih.gov/mesh/D016246Q000276
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D053246Q000276
http://id.nlm.nih.gov/mesh/D000911Q000008
http://id.nlm.nih.gov/mesh/D000911Q000276
http://id.nlm.nih.gov/mesh/D015703Q000235
http://id.nlm.nih.gov/mesh/D003713Q000276
http://id.nlm.nih.gov/mesh/D053245Q000235
http://id.nlm.nih.gov/mesh/D060908Q000235
http://id.nlm.nih.gov/mesh/D015703Q000276
http://id.nlm.nih.gov/mesh/D018414Q000276
http://id.nlm.nih.gov/mesh/D015972Q000276
http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c748933949594727af0f48c375532600
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3180f3560c702ffddc361716fecd9861

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21934
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12477
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21943

Total number of triples: 72.